CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-19 | Anzalone Christopher Richard Chief Executive Officer | Sale 10b5-1 | −1,319 | $68.48 | $90K | 3,818,512 |
| 2025-12-19 | OLUKOTUN ADEOYE Y Director | Sale 10b5-1 | −3,090 | $66.70 | $206K | 40,510 |
| 2025-12-19 | OLUKOTUN ADEOYE Y Director | Sale 10b5-1 | −6,083 | $68.04 | $414K | 34,427 |
| 2025-12-19 | OLUKOTUN ADEOYE Y Director | Sale 10b5-1 | −827 | $68.48 | $57K | 33,600 |
| 2025-12-17 | Anzalone Christopher Richard Chief Executive Officer | Sale | −46,287 | $63.55 | $2.9M | 3,870,670 |
| 2025-12-17 | Anzalone Christopher Richard Chief Executive Officer | Sale | −35,750 | $64.51 | $2.3M | 3,834,920 |
| 2025-12-17 | Anzalone Christopher Richard Chief Executive Officer | Sale | −982 | $65.53 | $64K | 3,833,938 |
| 2025-12-17 | Anzalone Christopher Richard Chief Executive Officer | Sale | −1,981 | $66.30 | $131K | 3,831,957 |
| 2025-12-16 | Vakiener Victoria Director | Grant or award | +7,819 | 45,763 | ||
| 2025-12-16 | Lu Hongbo Director | Grant or award | +7,819 | 54,982 | ||
| 2025-12-16 | Waddill William D. Director | Grant or award | +7,819 | 64,930 | ||
| 2025-12-16 | Ferrari Mauro Director | Grant or award | +7,819 | 76,583 | ||
| 2025-12-16 | PERRY MICHAEL S Director | Grant or award | +7,819 | 123,059 | ||
| 2025-12-16 | OLUKOTUN ADEOYE Y Director | Grant or award | +7,819 | 43,600 | ||
| 2025-12-16 | INGRAM DOUGLAS S Director | Grant or award | +7,819 | 46,215 | ||
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −8,416 | $60.51 | $509K | 3,962,839 |
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −10,963 | $61.25 | $671K | 3,951,876 |
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −14,095 | $62.12 | $876K | 3,937,781 |
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −8,476 | $62.94 | $533K | 3,929,305 |
| 2025-12-16 | Anzalone Christopher Richard Chief Executive Officer | Sale | −6,661 | $64.29 | $428K | 3,922,644 |
Page 4 of 28 · 542 trades